Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs.

Banerjee AA, Shen H, Hautman M, Anwer J, Hong S, Kapetanovic IM, Liu Y, Lyubimov AV.

Curr Pharm Biotechnol. 2013;14(4):464-9.

PMID:
23590143
2.

Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading.

Shen H, Banerjee AA, Mlynarska P, Hautman M, Hong S, Kapetanovic IM, Lyubimov AV, Liu Y.

J Pharm Sci. 2012 Oct;101(10):3877-85. doi: 10.1002/jps.23269. Epub 2012 Jul 20.

PMID:
22821759
3.

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys.

Kapetanovic IM, Muzzio M, Hu SC, Crowell JA, Rajewski RA, Haslam JL, Jong L, McCormick DL.

Cancer Chemother Pharmacol. 2010 May;65(6):1109-16. doi: 10.1007/s00280-009-1116-4. Epub 2009 Sep 16.

PMID:
19756605
4.

Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles.

Shen H, Hu X, Szymusiak M, Wang ZJ, Liu Y.

Mol Pharm. 2013 Dec 2;10(12):4546-51. doi: 10.1021/mp400358z. Epub 2013 Nov 19.

5.

The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.

Ma Y, Zhao X, Li J, Shen Q.

Int J Nanomedicine. 2012;7:559-70. doi: 10.2147/IJN.S27641. Epub 2012 Feb 2.

6.

Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.

Green CE, Swezey R, Bakke J, Shinn W, Furimsky A, Bejugam N, Shankar GN, Jong L, Kapetanovic IM.

Cancer Chemother Pharmacol. 2011 May;67(5):995-1006. doi: 10.1007/s00280-010-1395-9. Epub 2010 Jul 10.

8.

Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.

Kumar G, Sharma S, Shafiq N, Pandhi P, Khuller GK, Malhotra S.

Drug Deliv. 2011 Jan;18(1):65-73. doi: 10.3109/10717544.2010.509367. Epub 2010 Aug 24.

PMID:
20735202
9.

Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.

Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J.

Eur J Pharm Sci. 2012 Apr 11;45(5):632-8. doi: 10.1016/j.ejps.2012.01.002. Epub 2012 Jan 10.

PMID:
22248882
10.
11.

Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.

He W, Horn SW, Hussain MD.

Int J Pharm. 2007 Apr 4;334(1-2):173-8. Epub 2006 Oct 21.

PMID:
17101249
12.

Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.

Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN.

J Control Release. 2007 May 14;119(1):77-85. Epub 2007 Feb 3.

PMID:
17349712
13.

Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential.

Singh G, Pai RS.

Expert Opin Drug Deliv. 2014 May;11(5):647-59. doi: 10.1517/17425247.2014.890588. Epub 2014 Mar 24.

PMID:
24661109
14.

PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.

Li X, Xu Y, Chen G, Wei P, Ping Q.

Drug Dev Ind Pharm. 2008 Jan;34(1):107-15. doi: 10.1080/03639040701484593 .

PMID:
18214762
15.

HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.

Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ.

Int J Pharm. 2012 Apr 4;425(1-2):1-8. doi: 10.1016/j.ijpharm.2011.12.055. Epub 2012 Jan 12.

PMID:
22248666
16.

Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.

Ling G, Zhang P, Zhang W, Sun J, Meng X, Qin Y, Deng Y, He Z.

J Control Release. 2010 Dec 1;148(2):241-8. doi: 10.1016/j.jconrel.2010.08.010. Epub 2010 Aug 18.

PMID:
20727928
17.

PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.

Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, Wang H, Zhou Q, Yu S.

J Agric Food Chem. 2011 Sep 14;59(17):9280-9. doi: 10.1021/jf202135j. Epub 2011 Aug 8.

PMID:
21797282
18.

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

Feng SS, Mei L, Anitha P, Gan CW, Zhou W.

Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

PMID:
19299012
19.

Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.

Joshi G, Kumar A, Sawant K.

Eur J Pharm Sci. 2014 Aug 18;60:80-9. doi: 10.1016/j.ejps.2014.04.014. Epub 2014 May 6.

PMID:
24810394
20.

Folic acid functionalized nanoparticles for enhanced oral drug delivery.

Roger E, Kalscheuer S, Kirtane A, Guru BR, Grill AE, Whittum-Hudson J, Panyam J.

Mol Pharm. 2012 Jul 2;9(7):2103-10. doi: 10.1021/mp2005388. Epub 2012 Jun 13.

Supplemental Content

Support Center